Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,950.00
+290.00 (3.35%)
At close: Oct 2, 2025
3.35%
Market Cap204.03B
Revenue (ttm)8.27B
Net Income (ttm)-1.28B
Shares Out23.89M
EPS (ttm)-53.69
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume57,204
Average Volume53,565
Open8,680.00
Previous Close8,660.00
Day's Range8,680.00 - 9,140.00
52-Week Range4,633.33 - 13,200.00
Beta0.62
RSI44.33
Earnings Daten/a

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.